Literature DB >> 23188874

Good's syndrome and IgA monoclonal gammopathy of undetermined significance.

Erwan Oehler1, Laurence Heuberger, Frédéric Ghawche, Florent Valour.   

Abstract

Characterised by the association of a thymoma, hypogammaglobulinaemia, and B-cell and T-cell dysfunction, Good's syndrome (GS) is a rare cause of adult immunodeficiency leading to recurrent infections, and autoimmune manifestations related to the thymoma. We describe a 70-year-old woman in whom the diagnosis of GS was made after 7 years follow-up of a monoclonal gammopathy of undetermined significance (MGUS). After thymectomy, she received monthly intravenous immunoglobulin perfusions in order to maintain a normal plasmatic IgG level. To our knowledge, this is the fifth described case of GS associated with an MGUS. This rare condition should not be misdiagnosed, as the prognosis is determined by infectious and autoimmune complications, which could be prevented.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23188874      PMCID: PMC4544257          DOI: 10.1136/bcr-2012-007601

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

Review 1.  Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies.

Authors: 
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

Review 2.  What is Good's syndrome? Immunological abnormalities in patients with thymoma.

Authors:  P Kelleher; S A Misbah
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

3.  Good's syndrome.

Authors:  Ida W Y Wong; K K Chan; K S Chan
Journal:  Hong Kong Med J       Date:  2008-06       Impact factor: 2.227

4.  Sweet's syndrome in a patient with idiopathic myelofibrosis and thymoma-myasthenia gravis-immunodeficiency complex: efficacy of treatment with etretinate.

Authors:  G Altomare; G L Capella; E Frigerio
Journal:  Haematologica       Date:  1996 Jan-Feb       Impact factor: 9.941

5.  Pure red cell aplasia associated with Good's syndrome accompanied by decreased stem cell factor production in the bone marrow.

Authors:  Kageaki Kuribayashi; Akihito Fujimi; Masayoshi Kobune; Rishu Takimoto; Shohei Kikuchi; Satoshi Iyama; Junji Kato; Yoshiro Niitsu; Naoki Watanabe
Journal:  Intern Med       Date:  2010-03-01       Impact factor: 1.271

Review 6.  Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature.

Authors:  P E Tarr; M C Sneller; L J Mechanic; A Economides; C M Eger; W Strober; C Cunningham-Rundles; D R Lucey
Journal:  Medicine (Baltimore)       Date:  2001-03       Impact factor: 1.889

Review 7.  Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence.

Authors:  Theodoros Kelesidis; Otto Yang
Journal:  Clin Immunol       Date:  2010-02-10       Impact factor: 3.969

8.  Prevalence of monoclonal gammopathy of undetermined significance.

Authors:  Robert A Kyle; Terry M Therneau; S Vincent Rajkumar; Dirk R Larson; Matthew F Plevak; Janice R Offord; Angela Dispenzieri; Jerry A Katzmann; L Joseph Melton
Journal:  N Engl J Med       Date:  2006-03-30       Impact factor: 91.245

9.  Thymoma with immunodeficiency (Good's syndrome) associated with myasthenia gravis and benign IgG gammopathy.

Authors:  E Soppi; J Eskola; M Röyttä; T Veromaa; M Panelius; A Lehtonen
Journal:  Arch Intern Med       Date:  1985-09

10.  Thymoma with immunodeficiency (Good's syndrome) associated with selective cobalamin malabsorption and benign IgM-kappa gammopathy.

Authors:  C Jeandel; I Gastin; H Blain; P Jouanny; M C Laurain; F Penin; M Saunier; J P Nicolas; J L Guéant
Journal:  J Intern Med       Date:  1994-02       Impact factor: 8.989

View more
  1 in total

1.  Two Independent Hematological malignancies in a B-Cell Deficient Good Syndrome Patient.

Authors:  Marvyn T Koning; André P van Rossum; Nicolette L Tiren-Verbeet; Jacobus A Burgers; A Faiz Karim
Journal:  Rheumatology (Oxford)       Date:  2021-04-06       Impact factor: 7.580

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.